Relos, Dyesebel .

HRN: 26-20-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
CEFTRIAXONE 1G (VIAL)
11/15/2024
11/22/2024
IV
2 Grams
OD
Dengue Fever With Warning Signs
Waiting Final Action 
11/15/2024
CEFUROXIME 750MG (VIAL)
11/15/2024
11/22/2024
IV
750mg
Q 8hrs
Dengue Fever With Warning Signs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: